https://www.indianpharmapost.com/tatva-chintan-q2-fy23-revenue-down-27-net-profit-down-78-132602022-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/iolcp-receives-edqm-certification-to-supply-pantoprazole-sodium-sesquihydrate-api-in-europe-132612022-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/balaxi-pharmaceuticals-delivers-strong-growth-in-q2-fy23-132622022-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-receives-tentative-approval-from-usfda-for-drospirenone-tablets-132632022-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/empa-kidney-trial-showed-significant-benefit-of-jardiance-in-reducing-kidney-disease-progression-132642022-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/rossari-biotech-q2-fy23-revenue-up-11-profit-down-9-132652022-11-07T00:00:00+05:30always0.9